Neuroone Medical Technologies Corp (NASDAQ:NMTC) — Stock Price
Neuroone Medical Technologies Corp (NASDAQ:NMTC) is currently trading at $1.56 USD, down 4.29% today. Over the past 52 weeks, shares have ranged between $0.59 and $5.11. This page tracks Neuroone Medical Technologies Corp's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Neuroone Medical Technologies Corp worth.
Neuroone Medical Technologies Corp (NMTC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Neuroone Medical Technologies Corp's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Neuroone Medical Technologies Corp Income Statement — Revenue, Profit & Earnings by Year
Neuroone Medical Technologies Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $12.10 Million | $3.45 Million | $1.95 Million | $171.17K | $178.15K |
| Cost of Revenue | $3.96 Million | $2.37 Million | $1.50 Million | $241.96K | $275.89K |
| Gross Profit | $8.14 Million | $1.08 Million | $456.52K | $-70.79K | $-97.75K |
| Research & Development | $4.98 Million | $5.07 Million | $6.94 Million | $4.93 Million | $3.93 Million |
| SG&A | $7.38 Million | $7.79 Million | $6.75 Million | $6.71 Million | $5.92 Million |
| Total Operating Expenses | $12.37 Million | $12.97 Million | $12.41 Million | $9.96 Million | $10.12 Million |
| Operating Income | $-4.23 Million | $-11.89 Million | $-11.96 Million | $-10.03 Million | $-10.22 Million |
| EBITDA | $-3.01 Million | $-11.84 Million | $-11.76 Million | $-9.91 Million | $-9.80 Million |
| EBIT | $-3.27 Million | $-12.09 Million | $-11.96 Million | $-10.03 Million | $-9.95 Million |
| Interest Expense | $334.06K | $228.99K | $0.00 | $31.15K | $3.05K |
| Income Before Tax | $-3.61 Million | $-12.32 Million | $-11.86 Million | $-10.00 Million | $-9.95 Million |
| Income Tax Expense | — | — | $31.37K | $-109.86K | $274.18K |
| Net Income | $-3.61 Million | $-12.32 Million | $-11.86 Million | $-10.00 Million | $-9.95 Million |
Neuroone Medical Technologies Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Neuroone Medical Technologies Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $10.79 Million | $5.37 Million | $8.10 Million | $12.82 Million | $7.94 Million |
| Total Current Assets | $10.23 Million | $4.63 Million | $7.31 Million | $12.18 Million | $7.29 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | $0.00 | $2.98 Million | $0.00 |
| Net Receivables | $1.26 Million | $176.64K | $0.00 | $33.24K | $48.34K |
| Inventory | $2.23 Million | $2.64 Million | $1.73 Million | $704.54K | $98.29K |
| Property, Plant & Equipment | — | — | — | $534.95K | $512.28K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $3.71 Million | $4.55 Million | $1.85 Million | $3.22 Million | $1.38 Million |
| Total Current Liabilities | $2.30 Million | $2.21 Million | $1.79 Million | $3.10 Million | $1.18 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-6.30 Million | $-1.20 Million | $-5.14 Million | $-7.96 Million | $-6.59 Million |
| Total Stockholder Equity | $7.07 Million | $822.01K | $6.25 Million | $9.60 Million | $6.55 Million |
| Retained Earnings | $-78.61 Million | $-75.00 Million | $-62.69 Million | $-50.83 Million | $-40.83 Million |
Neuroone Medical Technologies Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Neuroone Medical Technologies Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-2.84 Million | $-11.01 Million | $-12.89 Million | $-7.52 Million | $-8.60 Million |
| Capital Expenditures | $81.74K | $120.20K | $384.12K | $275.23K | $67.08K |
| Free Cash Flow | $-2.92 Million | $-11.13 Million | $-13.27 Million | $-7.79 Million | $-8.67 Million |
| Investing Cash Flow | $-81.74K | $-120.20K | $2.65 Million | $-3.24 Million | $-67.08K |
| Financing Cash Flow | $8.03 Million | $7.27 Million | $7.40 Million | $12.02 Million | $11.53 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $1.26 Million | $1.34 Million | $1.11 Million | $947.21K | $1.79 Million |
| Depreciation | $261.68K | $246.79K | $199.27K | $118.62K | $80.75K |
| Change in Cash | $5.11 Million | $-3.86 Million | $-2.84 Million | $1.26 Million | $2.86 Million |
Neuroone Medical Technologies Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Neuroone Medical Technologies Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 13, 2026 | — | — | — |
| May 12, 2026 | -0.25 | -0.23 | -8.43% |
| Feb 17, 2026 | -0.18 | -0.24 | +25.00% |
| Dec 16, 2025 | -0.03 | -0.06 | +46.00% |
| Aug 14, 2025 | -0.18 | -0.30 | +40.00% |
| May 13, 2025 | -0.42 | -0.54 | +22.22% |
| Feb 12, 2025 | 0.36 | -0.60 | +160.00% |
| Dec 12, 2024 | -0.11 | -0.09 | -24.44% |